Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02392611
Title Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 in Adults With Advanced Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications

Advanced Solid Tumor

lymphoma

Therapies

Exemestane + GS-5829

Age Groups: adult
Covered Countries USA


No variant requirements are available.